Home » Topics » BioWorld Science

BioWorld Science
RSS

Five statins available in the U.S. as alternatives to Baycol

Aug. 20, 2001

Geron and Kyowa Hakko select telomerase inhibitor for development

Aug. 20, 2001

Encouraging phase I results reported for Supratek's lead oncology product

Aug. 20, 2001

Onyx regains development rights for nonintravenous administration of ONYX-015

Aug. 20, 2001

BioCryst's oral influenza neuraminidase inhibitor to enter phase III trial in U.S.

Aug. 20, 2001

LAR formulations of Amylin's synthetic exendin-4 offer potential for monthly dosing

Aug. 20, 2001

Lifestyle modification or Glucophage markedly reduce progression to type 2 diabetes

Aug. 20, 2001

Cataracts improve with N-acetylcarnosine drops

Aug. 20, 2001

Cyclic D,L-alpha peptides exert antibacterial activity against MRSA

Aug. 20, 2001

New antiarrhythmic agents identified at BMS

Aug. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...